Search results for "Bacterial"

showing 10 items of 3246 documents

Randomized Study of Early versus Late Immunization with Pneumococcal Conjugate Vaccine after Allogeneic Stem Cell Transplantation

2009

BACKGROUND: Invasive pneumococcal disease is a life-threatening complication after allogeneic stem cell transplantation, and at least 20% of cases occur within 1 year after transplantation. The 23-valent pneumococcal polysaccharide vaccine (PPV23) has limited efficacy, especially during the first year after transplantation. The immune response to the conjugated vaccines is expected to be better than that to the polysaccharide vaccine, but the optimal timing of vaccination is not defined. Our objective was to show that a 7-valent pneumococcal conjugate vaccine (PCV7; Prevnar) was not inferior when first given 3 months after transplantation, compared with when first given 9 months after trans…

AdultMaleMicrobiology (medical)Pediatricsmedicine.medical_specialtyHeptavalent Pneumococcal Conjugate VaccineTime FactorsAdolescentmedicine.medical_treatmentImmunization SecondaryHematopoietic stem cell transplantationPneumococcal conjugate vaccinePneumococcal VaccinesYoung AdultHeptavalent Pneumococcal Conjugate VaccineHumansMedicineChildImmunization Schedulebusiness.industryPneumococcal 7-Valent Conjugate VaccineMiddle AgedAntibodies BacterialPneumococcal polysaccharide vaccineEuropeVaccinationTransplantationInfectious DiseasesImmunizationImmunologyFemalebusinessImmunosuppressive AgentsStem Cell Transplantationmedicine.drugClinical Infectious Diseases
researchProduct

Presence of Rickettsia conorii subsp. israelensis , the Causative Agent of Israeli Spotted Fever, in Sicily, Italy, Ascertained in a Retrospective St…

2005

ABSTRACT A retrospective analysis by molecular-sequence-based techniques was performed to correctly identify the etiological agent of 24 Mediterranean spotted fever cases occurring in Western Sicily, Italy, from 1987 to 2001. Restriction analysis of a 632-bp PCR-amplified portion of the ompA gene allowed presumptive identification of five clinical isolates as belonging to Rickettsia conorii subsp. israelensis , the etiological agent of Israeli spotted fever (ISF). The remaining 19 rickettsial isolates were Rickettsia conorii subsp. conorii , the only pathogenic rickettsia of the spotted fever group reported in Italy until the present. Sequence analysis of the ompA gene confirmed the identif…

AdultMaleMicrobiology (medical)Settore MED/07 - Microbiologia E Microbiologia ClinicaChlamydiology and RickettsiologyMolecular Sequence DataBiologyBoutonneuse FeverRickettsiaceaeMicrobiologymedicineHumansIsraelAgedRetrospective StudiesRetrospective cohort studySequence Analysis DNAMiddle Agedmedicine.diseasebiology.organism_classificationVirologySpotted feverBoutonneuse feverRickettsia conoriiRickettsiosisRickettsiaItalyBacteria (microorganisms) Rickettsia Rickettsia conoriibacteriaFemaleRickettsia conoriiRickettsialesBacterial Outer Membrane ProteinsJournal of Clinical Microbiology
researchProduct

The Acute Phase Response in Sicilian Patients with Boutonneuse Fever Admitted to Hospitals in Palermo, 1992–1997

2001

Abstract Objectives : To study the modifications of some components of the acute phase response (APR) in Sicilian patients with boutonneuse fever (BF) caused by Rickettsia conorii . Methods : Sera from 500 Sicilian patients with confirmed BF were studied at the time of diagnosis and every week after treatment, and after recovery for the presence of various inflammatory mediators. Tumour necrosis factor α (TNFα), interleukin(IL)-6, IL-1α, IL-8, soluble TNF receptors (sTNF-R) and sIL-6R were assayed by commercially ELISA kits. C3, C4, factor B, C-reactive protein (CRP), fibrinogen, ceruloplasmin (Cp) and α 1 -antitrypsin (AAT) were assayed by a rate nephelometry. Results : Interferon gamma (I…

AdultMaleMicrobiology (medical)Time Factorsmedicine.medical_treatmentBoutonneuse FeverFibrinogenmedicineHumansInterferon gammaAcute-Phase ReactionAgedbiologybusiness.industryAcute-phase proteinInterleukinMiddle Agedmedicine.diseasebiology.organism_classificationAntibodies BacterialBoutonneuse feverRickettsia conoriiInfectious DiseasesCytokineItalyImmunologyCytokinesFemaleTumor necrosis factor alphaRickettsia conoriibusinessAcute-Phase Proteinsmedicine.drugJournal of Infection
researchProduct

LIODetect®TB-ST: Evaluation of novel blood test for a rapid diagnosis of active pulmonary and extra-pulmonary tuberculosis in IGRA confirmed patients

2021

Abstract Because of the current limits of immunological tests in the diagnosis of tuberculosis there is a need to identify new and rapid tests that can be carried out on a large scale in endemic countries and useful in the identification of infected subjects, but also able to discriminate those with latent infection from subjects with active. We have taken into consideration and analysed the LIODetect®TB-ST Tuberculosis Rapid Test, a membrane test for the qualitative detection of specific IgG, IgA, and IgM antibodies against Mycobacterium tuberculosis, performed on serum, plasma, or whole blood.85 samples positive to QuantiFERON TB-GOLD PLUS test were processed using this test and the resul…

AdultMaleMicrobiology (medical)TuberculosisIgm antibodyImmunologyDiseaseSensitivity and SpecificityMicrobiologyQuantiferon TB GoldQuantiFERONMycobacterium tuberculosisExtra pulmonary tuberculosisPLUSHumansTuberculosisMedicineBlood testTuberculosis PulmonaryIFN-γHematologic Testsbiologymedicine.diagnostic_testbusiness.industrySpecific iggMycobacterium tuberculosisMiddle Agedbiology.organism_classificationmedicine.diseaseAntibodies BacterialInfectious DiseasesImmunologyFemalebusinessLIODetect®TB-STInterferon-gamma Release Tests
researchProduct

Assessment of Analysis of Urinary Pneumococcal Antigen by Immunochromatography for Etiologic Diagnosis of Community-Acquired Pneumonia in Adults

2006

ABSTRACT The limitations of conventional microbiologic methods (CMM) for etiologic diagnosis of community pneumococcal pneumonia have made faster diagnostic techniques necessary. Our aim was to evaluate the usefulness of the immunochromatography (ICT) technique for detecting urinary Streptococcus pneumoniae antigen in the etiologic diagnosis of community-acquired pneumonias (CAP). This was a prospective study on in-patients with CAP in a tertiary hospital conducted from October 2000 to March 2004. Apart from using CMM to reach an etiologic diagnosis, we determined pneumococcal antigen in concentrated urine by ICT. We also determined the urinary pneumococcal antigen (UPA) content in patients…

AdultMaleMicrobiology (medical)medicine.medical_specialtyAdolescentClinical BiochemistryImmunologymedicine.disease_causeCommunity-acquired pneumoniaInternal medicineStreptococcus pneumoniaemedicineHumansImmunology and AllergyProspective StudiesAgedAged 80 and overAntigens BacterialChromatographyCOPDbusiness.industryClinical and Diagnostic Laboratory ImmunologyRespiratory infectionMiddle AgedPneumonia Pneumococcalmedicine.diseaseCommunity-Acquired InfectionsPneumoniaPneumococcal infectionsStreptococcus pneumoniaePneumococcal pneumoniaImmunologyImmunologic TechniquesEtiologyFemalebusinessClinical and Vaccine Immunology
researchProduct

Selective decontamination of the digestive tract in adult-to-adult living related liver transplant patients: a single centre experience

2008

AdultMaleMicrobiology (medical)medicine.medical_specialtyAdolescentSelective decontaminationSettore BIO/19 - Microbiologia GeneraleChemopreventionPostoperative ComplicationsmedicineHumansPharmacology (medical)Intensive care medicineDecontaminationAgedANTIBIOTIC THERAPY SELECTIVE DECONTAMINATION GRAM POSITIVE AND GRAM NEGATIVE BACTERIA TRANSPLANTbusiness.industryBacterial InfectionsGeneral MedicineMiddle AgedAnti-Bacterial AgentsLiver TransplantationGastrointestinal TractSingle centreInfectious DiseasesFemaleTransplant patientDigestive tractbusinessInternational Journal of Antimicrobial Agents
researchProduct

Prevalence of surgical site infections before and after the implementation of a multimodal infection control programme

2012

Objectives: In order to assess the prevalence of surgical site infections (SSIs) before and after the implementation of a multimodal infection control programme including the realization of a campaign to increase compliance with guidelines for antimicrobial prophylaxis, we designed and conducted the present study involving all 20 of the surgical departments of a large teaching hospital in Catania, Italy. Patients and methods: SSI definitions of the Hospital in Europe Link for Infection Control through Surveillance (HELICS) protocol were used in four 1 day point-prevalence surveys. After the first survey, an infection control programme was implemented involving the active commitment of surge…

AdultMaleMicrobiology (medical)medicine.medical_specialtyEvidence-based practiceSettore MED/42 - Igiene Generale E ApplicataSurgical sitePrevalencemedicineHumansSurgical Wound InfectionInfection controlPharmacology (medical)Antibiotic prophylaxisIntensive care medicineAgedPharmacologyInfection Controlbusiness.industryAntibiotic ProphylaxisMiddle AgedHospitalsantimicrobial prophylaxis guidelines compliance SSIsAnti-Bacterial AgentsInfectious disease prevention / controlInfectious DiseasesItalyFemaleGuideline AdherenceHealth Services ResearchbusinessJournal of Antimicrobial Chemotherapy
researchProduct

Presentation and outcome of infective endocarditis in Spain: a retrospective study

2007

Summary Objective To analyze cases of infective endocarditis in patients who attended the Hospital General de Castellon, Spain, between 1999 and 2004. Methods This was a retrospective study. Demographic and clinical characteristics were assessed, variation in presentation over time was analyzed, and factors influencing outcome were determined. Results A total of 54 cases in 48 patients were included; 33 (61%) were in men. The median patient age was 62 years. Infective endocarditis occurred on a native valve in 36 cases (67%), a mechanical prosthetic valve in 12 (22%), and a pacemaker in six (11%). The mitral valve was the most commonly affected site. Transthoracic and/or transesophageal ech…

AdultMaleMicrobiology (medical)medicine.medical_specialtyHeart diseaseWhite blood cellMitral valvemedicineHumansEndocarditisHeart valveAgedRetrospective Studiesbusiness.industryIncidenceIncidence (epidemiology)Retrospective cohort studyEndocarditis BacterialGeneral MedicineMiddle Agedmedicine.diseaseAnti-Bacterial AgentsSurgeryInfectious Diseasesmedicine.anatomical_structureSpainInfective endocarditisFemaleInfective endocarditisbusinessInternational Journal of Infectious Diseases
researchProduct

What are the risk factors for postoperative infections of third molar extraction surgery: A retrospective clinical study-?

2018

Background This study aimed to identify (1) the predilection site of postoperative infection after third molar extraction surgery, (2) risk factors associated with postoperative infection, and (3) the cause of the difference between delayed- and early-onset infections. Material and Methods This retrospective study included 1010 patients (396 male, 614 female) who had ≥1 third molars extracted (2407; 812 maxilla, 1595 mandible). The risk factors were classified as attributes, general health, anatomic, and operative. Outcome variables were delayed- and early-onset infections. Results Postoperative infection was completely absent in the maxilla, and all infections occurred in the mandible, wit…

AdultMaleMolarmedicine.medical_specialtyRetrospective dataClinical study03 medical and health sciencesPostoperative Complications0302 clinical medicinestomatognathic systemRisk FactorsPostoperative infectionmedicineHumansMandibular DiseasesGeneral DentistryRetrospective Studiesbusiness.industryResearchMandibleRetrospective cohort studyBacterial Infections030206 dentistry:CIENCIAS MÉDICAS [UNESCO]SurgeryOtorhinolaryngology030220 oncology & carcinogenesisMaxillaTooth ExtractionUNESCO::CIENCIAS MÉDICASFemaleMolar ThirdSurgeryGeneral healthOral SurgerybusinessThird molar extraction surgery; delayed-onset infection; early-onset infection; postoperative infectionMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Once-Daily Oral Levofloxacin Monotherapy versus Piperacillin/Tazobactam Three Times a Day: A Randomized Controlled Multicenter Trial in Patients with…

2004

A prospective, randomized, controlled multicenter trial was performed to evaluate the efficacy and safety of once-daily oral monotherapy with 500 mg levofloxacin in comparison with 4.5 g piperacillin/tazobactam 3 times a day in patients with low-risk febrile neutropenia. Low risk was defined by oral temperatureor = 38.5 degrees C on one occasion oror = 38.0 degrees C twice within 24 hours and granulocytopeniaor = 500/microL for less than 10 days. The primary end point was defined as defervescence after 72 hours followed by at least 7 afebrile days. Secondary end points were overall response, time to defervescence, survival on day 30, and toxicity. Thirty-four episodes were included. Fever o…

AdultMaleOfloxacinTazobactammedicine.medical_specialtyNeutropeniaFeverAdministration OralPenicillanic AcidAntineoplastic AgentsLevofloxacinNeutropeniaFever of Unknown OriginTazobactamDrug Administration ScheduleImmunocompromised HostLevofloxacinNeoplasmsInternal medicineMulticenter trialHumansMedicineProspective StudiesAgedAntibacterial agentPiperacillinbusiness.industryBacterial InfectionsHematologyMiddle Agedmedicine.diseaseSurgeryTreatment OutcomePiperacillin/tazobactamDrug Therapy CombinationFemaleDisease SusceptibilitySafetybusinessFebrile neutropeniaPiperacillinmedicine.drugInternational Journal of Hematology
researchProduct